subject: breastfeeding education

Vaccinating While Lactating: COVID-19 Vaccines Are Safe and Provide Immune Benefits to Mother and Infant

Vaccinating While Lactating: COVID-19 Vaccines Are Safe and Provide Immune Benefits to Mother and Infant

Less than a year from the first recorded SARS-CoV-2 infection in the U.S., the Food and Drug Administration (FDA) authorized the emergency use of three COVID-19 vaccines. Usually a decade long endeavor, the global pandemic that has claimed over three million lives necessitated a rapid and all-hands-on-deck approach to vaccine development and delivery. Even with the accelerated pace, the vaccine trials made sure to include a diverse group of adults across multiple races, ethnicities, and age groups to ensure vaccine safety and efficacy for all recipients. What this diverse group did not include, however, were breastfeeding mothers. Without any clinical data to guide their vaccination decision, what’s a mother to do? Read More...

Colostrum Through a Cultural Lens

Colostrum Through a Cultural Lens

In the first hours and days after a human baby is born, mothers aren't producing the white biofluid that typically comes to mind when we think about milk. They synthesize a yellowish milk known as colostrum or "pre-milk." Colostrum is the first substance human infants are adapted to consume, and despite being low in fat, colostrum plays many roles in the developing neonate. Historically and cross-culturally, colostrum was viewed very differently than it is amongst industrialized populations today. Read More...

Drugs to Prevent HIV Infection are Barely Present in Human Milk

Drugs to Prevent HIV Infection are Barely Present in Human Milk

The World Health Organization considers someone with more than a 3% chance of contracting HIV in the next year to have a “substantial” risk of infection. This is important because it is the cut-off for which the WHO recommends taking anti-retroviral drugs, like tenofovir, to reduce the odds of infection. Breastfeeding women in sub-Saharan Africa easily meet this risk threshold. But medical professionals are discouraged from offering the drug to these women because of WHO warning labels about potential adverse reactions in nursing infants. That advice may now change, paving the way for many more at-risk women to receive HIV prophylaxis. A new study shows that when infants consume human milk from a woman taking tenofovir in combination with emtricitabine, they are exposed to extremely low levels of The World Health Organization considers someone with more than a 3% chance of contracting HIV in the next year to have a “substantial” risk of infection. This is important because it is the cut-off for which the WHO recommends taking anti-retroviral drugs, like tenofovir, to reduce the odds of infection. A new study shows that when infants consume human milk from a woman taking tenofovir in combination with emtricitabine, they are exposed to extremely low levels of either drug.drug. Therefore, the infants’ likelihood of experiencing adverse reactions is virtually non-existent. Read More...

Meet our Elite and Premier Sponsors